At LeafLine Labs, we know that exceptional patient care starts with an extraordinary team. That’s why we pride ourselves on our people. Get to know us, why dontcha? Meet Amy, a Pharmacist at our Saint Paul patient care center.
Post-traumatic stress disorder (PTSD) became a qualifying condition for the medical cannabis program in Minnesota on August 1, 2017.
PTSD is a mental health disorder that manifests after a traumatic event. Symptoms of PTSD are varied but often include: disturbed sleep, anxiety (specifically when in a situation similar or reminiscent of the traumatic event(s), flashbacks, and more.
In severe cases of PTSD, these symptoms can greatly impact daily life. There is no cure for PTSD, but its symptoms can be managed with medication and therapy.
Arthritis itself is not a qualifying condition for the medical cannabis program in Minnesota, however, LeafLine Labs treats many patients with arthritis who have qualified for the medical cannabis program under Intractable Pain.
Medical cannabis’ ability to reduce pain and inflammation is well established, and many patients currently being treated for arthritis symptoms at our care centers have reported greatly improved symptoms.
For patients with Inflammatory Bowel Disease and Crohn’s Disease, pharmacists typically recommend products, or combinations of products, that provide ample CBD levels with a smaller amount of THC.
Cannabis has anti-secretory effects and decreases intestinal motility, therefore reducing the frequency of loose stools or diarrhea.
CBD is highly effective as an anti-inflammatory agent; studies have reported CBD is anywhere from 4 to 20 times more potent than aspirin as an anti-inflammatory. CBD also mitigates certain effects of THC; by using higher amounts of CBD than THC, patients experience the benefits of THC with a smaller chance of undesired effects such as sedation or dizziness, allowing them to be more active during the day.
Tangerine, our high-THC and low-CBD formulation, is our most commonly used medication for cancer patients.
THC often gets a bad rap, but provides a lengthy list of therapeutic benefits such as: decreasing pain, improving appetite, increasing weight gain, and improving sleep. THC is also known for its anti-nausea, anti-emetic (vomiting) and anti-anxiety properties.
The small amount of CBD that is in this product has anti-inflammatory properties. CBD helps to improve the anti-nausea, anti-emetic and anti-anxiety properties of THC, which are helpful in progressive diseases as well as during and after chemotherapy.
Lisa of Apple Valley, Minnesota, is a mother to twin daughters, a wife, and Marriage and Family Counselor. Her husband, Mark, is a stay-at-home father. Together, they have worked hard to build the life they have always dreamed of.
Lisa had a lumpectomy when she was just 17. At age 22, she was told she had rheumatoid arthritis; the pain was so profound at one point that she was confined to a wheelchair. Years later she was diagnosed with metastatic breast cancer and Hodgkin’s lymphoma.
“I remember looking at my nightstand and my Oxycodone was half full. Half full, not empty,” Lisa recalled. “And I panicked. I thought, I need more. And I wasn’t even close to being done with it. It was just that fear the pain would come back.”
Hiroki of Cottage Grove, Minnesota, is 8 years old. Cognitively, he has progressed to approximately age 2. His smile can light up even the darkest of rooms. He enjoys spending time with his family and playing with his younger brother, Taiyo. He loves to walk with his parents, grandma or his professional au pair to the mailbox each day. Hiroki becomes giddy with excitement when he knows it’s time; weather permitting, they venture past the mailbox and toward his favorite fence so he can run his hands along it and then take a long walk around the neighborhood.
At the time of his diagnosis at 1 years old, Hiroki was 1 of 600 in the world known to have Phelan-McDermid syndrome (PMS), a rare genetic condition commonly characterized by intellectual disability of varying degrees, delayed or absent speech, low muscle tone, seizures, and motor delays.
Lucas of Lakeville, Minnesota, is in many ways your typical 18-year-old boy. He loves girls, Will Ferrell movies, and sports--baseball is his favorite. He also loves some good potty humor, Elmo, and spending time with his big sister.
At age 3, Lucas was diagnosed on the autism spectrum and with cerebral palsy. Around the same age, his parents were told that he also suffered from seizures.
In addition to the seizures, Lucas would often inflict harm on himself or others. He was anxious, restless and would often struggle to get restful sleep. Some of Lucas’s behavioral tendencies has made it hard for his family to spend time out in their community. “Autism is our life,” his mother explained. Lucas and his family have spent many days at home watching TV.
Meet Tony, a LeafLine Labs patient who lives in Apple Valley, Minnesota. He is your not-so-typical ‘retired’ (as he likes to call it) 25 year old. He graduated from Augsburg College with a degree in Management Information Systems. He’s sharp, smart, and has a great sense of humor. A self-proclaimed music critic, he runs his own blog where he shares his thoughts on the best and worst of the industry. He enjoys going to movies, playing video games, and spending time outside as much as he can.
Tony grew up walking, running, and participating in all the activities of a typical childhood. When he was 4 ½ years old, he started showing signs of Duchenne Muscular Dystrophy (DMD), a disorder of progressive muscular weakness most commonly found in boys. To help manage symptoms of DMD, Tony began taking steroid injections.
In order to best serve and care for you, our growing community of patients, we have decided to adjust our hours of operations at our patient care centers across the state. As new conditions and patients come to the program, we have a responsibility to you, the LeafLine Labs team, and the State of Minnesota to operate efficiently and responsibly. In alignment with the shift in hours and to accommodate increased demand, we are no longer able to accommodate walk-ins for consultations, which means all consultations will need to be scheduled on an appointment-only basis going forward.